Learn more about whether Alkermes plc or BioCryst Pharmaceuticals, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

A professor in Enzyme and Environmental Biotechnology at the Federal University of Technology, Akure (FUTA), Olajuyigbe, has called for increased strategic investment in enzyme biotechnology as a ...

With one of the most densely concentrated life sciences hubs in Europe, the Netherlands sets its sights on becoming a global biotech leader.

This pharmaceutical biotechnology company announced a significant milestone in its global intellectual property strategy. The ...

The global cell culture incubator market is poised for robust expansion, projected to grow from USD 2,621.4 million in 2025 to approximately USD 4,873.8 million by 2035, reflecting a compound annual ...

Learn more about whether BioCryst Pharmaceuticals, Inc. or Ionis Pharmaceuticals, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

A Scottish biotech start-up is gearing up to expand into new markets with the development of a new high-value food ingredient ...

The world market for recombinant proteins remains strong, with North America and Europe dominating research and development as a result of their strong biopharmaceutical industries. The Asia-Pacific ...

Although gene-editing and other techniques can improve the production of microbe-based biologics, AI could push these drugs ...

Building a chromosome from scratch may sound like science fiction, but scientists have actually done it-and made it work. In ...